State of Wisconsin Investment Board’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-727,668
Closed -$1.64M 2032
2020
Q3
$1.64M Hold
727,668
﹤0.01% 1192
2020
Q2
$2.6M Sell
727,668
-309,862
-30% -$1.12M 0.01% 1079
2020
Q1
$3.94M Buy
1,037,530
+887,500
+592% +$2.92M 0.01% 878
2019
Q4
$452K Buy
+150,030
New +$390K ﹤0.01% 1473

Other funds holding BMY.RT

State of Wisconsin Investment Board's BMY.RT Position: Q4 2020 in Review

State of Wisconsin Investment Board sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q4 2020, closing a stake of 727,668 shares — an estimated $1.64M sold.

State of Wisconsin Investment Board first reported a position in BMY.RT in Q4 2019 and held it in 4 quarters. The position peaked at $3.94M in Q1 2020. 546 funds tracked by Wall St. Rank hold BMY.RT as of Q4 2020.

  • State of Wisconsin Investment Board reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q4 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 727,668 Bristol-Myers Squibb Company Contingent Value Rights shares in Q4 2020, an estimated $1.64M.
  • State of Wisconsin Investment Board first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 4 quarters.
  • State of Wisconsin Investment Board's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $3.94M in Q1 2020.
  • 546 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q4 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2020, filed 3 Feb 2021.